• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

TASP0390325

CAS No. 1642187-96-9

TASP0390325 ( —— )

产品货号. M34441 CAS No. 1642187-96-9

TASP0390325 是一种高亲和力的、具有口服活性的精氨酸加压素受体 1B(V1B 受体)拮抗剂,具有抗抑郁和抗焦虑活性。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥672 有现货
5MG ¥993 有现货
10MG ¥1599 有现货
25MG ¥3558 有现货
50MG ¥6154 有现货
100MG ¥9792 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    TASP0390325
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    TASP0390325 是一种高亲和力的、具有口服活性的精氨酸加压素受体 1B(V1B 受体)拮抗剂,具有抗抑郁和抗焦虑活性。
  • 产品描述
    TASP0390325 is a high affinity and orally active arginine vasopressin receptor 1B (V1B receptor) antagonist with antidepressant and anxiolytic activities.
  • 体外实验
    TASP0390325 shows a high affinity and potent antagonist activity for V1B receptors. TASP0390325 dose-dependently inhibits [3H]-AVP binding to recombinant human V1B receptors with the IC50 value of 2.72 nM. TASP0390325 also inhibits [3H]-AVP binding to rat anterior pituitary membranes, with the IC50 value of 2.22 nM. TASP0390325 potently attenuates the 2.5 nM AVP-induced increase in [Ca2+]i, with IC50 values of and 20.2 nM.Pretreatment with TASP0390325 inhibits the retention of 11C-TASP699 in a dose-dependent manner. Binding of 11C-TASP699 to monkey pituitary slices is specifically localized to the anterior lobe. The radioligand binding is inhibited by TASP0390325 in a concentration-dependent manner. The IC50 value of TASP0390325 is 2.16 nM.
  • 体内实验
    TASP0390325 blocks the anterior pituitary V1B receptor in vivo. Oral administration of TASP0390325 antagonized the increase in plasma ACTH levels induced by CRF/dDAVP in rats, indicating that TASP0390325 blocks the anterior pituitary V1B receptor in vivo. TASP0390325 (1 mg/kg) significantly antagonizes CRF/dDAVP-induced plasma ACTH in rats.Oral administration of TASP0390325 also exerts antidepressant effects in two models of depression (a forced swimming test and an olfactory bulbectomy model).Animal Model:Male Sprague-Dawley (SD) rats (211-246 g) Dosage:0.3 and 1 mg/kg (TASP0390325 is suspended in 0.5% methylcellulose 400) Administration:Oral administration Result:Antagonized the increase in plasma ACTH levels induced by CRF/dDAVP in rats at a dose of 1 mg/kg. In contrast, 0.3 and 1.0 mg/kg itself did not significantly affect basal ACTH levels.
  • 同义词
    ——
  • 通路
    GPCR/G Protein
  • 靶点
    Vasopressin Receptor
  • 受体
    Vasopressin Receptor
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1642187-96-9
  • 分子量
    554.44
  • 分子式
    C25H30Cl2FN5O4
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO 中的溶解度 : 100 mg/mL (180.36 mM; 超声助溶 )
  • SMILES
    Cl.O=C1C2=CC(OCCCN3CCOCC3)=CN=C2N=C(C=4C=CC(F)=C(Cl)C4)N1CC(=O)NC(C)C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. M Iijima, et al. Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325. Br J Pharmacol. 2014 Jul;171(14):3511-25.?
产品手册
关联产品
  • Lixivaptan

    Lixivaptan 是一种口服活性、选择性加压素受体 V2 拮抗剂 (Ki = 2.3 nM)。

  • Fedovapagon

    Fedovapagon (VA106483) 是一种选择性的加压素 V2 受体 (V2R) 激动剂,EC50 值为24 nM。Fedovapagon 可用于夜尿症的研究。

  • OPC-51803

    OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.